 | Up a level |
Marzolini, Catia; Elzi, Luigia; Gibbons, Sara; Weber, Rainer; Fux, Christoph; Furrer, Hansjakob; Chave, Jean-Philippe; Cavassini, Matthias; Bernasconi, Enos; Calmy, Alexandra; Vernazza, Pietro; Khoo, Saye; Ledergerber, Bruno; Back, David; Battegay, Manuel; Swiss HIV Cohort Study, (2010). Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antiviral therapy, 15(3), pp. 413-23. London: International Medical Press 10.3851/IMP1540
Bucher, Heiner C; Rickenbach, Martin; Young, Jim; Glass, Tracy R; Vallet, Yannick; Bernasconi, Enos; Cavassini, Matthias; Fux, Christoph; Schiffer, Véronique; Vernazza, Pietro; Weber, Rainer; Battegay, Manuel; Swiss HIV Cohort Study, (2010). Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral therapy, 15(1), pp. 31-40. London: International Medical Press 10.3851/IMP1475
Gianella, Sara; von Wyl, Viktor; Fischer, Marek; Niederoest, Barbara; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Rauch, Andri; Hirschel, Bernard; Vernazza, Pietro; Weber, Rainer; Joos, Beda; Günthard, Huldrych F; Swiss HIV Cohort Study, (2011). Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antiviral therapy, 16(4), pp. 535-45. London: International Medical Press 10.3851/IMP1776
Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; Vernazza, Pietro; Hirschel, Bernard; Weber, Rainer; Furrer, Hansjakob; Stoeckle, Marcel; Bucher, Heiner C; Fux, Christoph Andreas; Swiss HIV, Cohort Study (2012). The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antiviral therapy, 18(3), pp. 337-344. London: International Medical Press 10.3851/IMP2372
Sambatakou, H; Dabis, F; Geffard, S; Smit, C; de Wolf, F; van der Meer, J; Peters, L; Puoti, M; Monforte, AD; Tural, C; Zinkernagel, A; Ledergerber, B; Rauch, A; de Witt, S; Suarez-Lozano, N (2012). Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration. Antiviral therapy, 17(8), pp. 1541-50. London: International Medical Press
Baur, Katharina; Mertens, Joachim C; Schmitt, Johannes; Iwata, Rika; Stieger, Bruno; Frei, Pascal; Seifert, Burkhardt; Bischoff Ferrari, Heike A; von Eckardstein, Arnold; Müllhaupt, Beat; Geier, Andreas; Swiss Hepatitis C Cohort Study Group, (2012). The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. Antiviral therapy, 17(3), pp. 541-7. London: International Medical Press 10.3851/IMP2018
Zinkernagel, AS; von Wyl, V; Ledergerber, B; Rickenbach, M; Furrer, H; Battegay, M; Hirschel, B; Tarr, PE; Opravil, M; Bernasconi, E; Schmid, P; Weber, R; Swiss, HIV Cohort Study (2006). Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antiviral therapy, 11(2), pp. 131-42. London: International Medical Press
Moore, David M; Hogg, Robert S; Braitstein, Paula; Wood, Evan; Yip, Benito; Montaner, Julio S G (2006). Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy. Antiviral therapy, 11(1), 125-9.. London: International Medical Press
Boulle, A; Orrel, C; Kaplan, R; Van Cutsem, G; McNally, M; Hilderbrand, K; Myer, L; Egger, M; Coetzee, D; Maartens, G; Wood, R; International, Epidemiological Databases to Evaluate Aids in Southern Africa Co (2007). Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antiviral therapy, 12(5), pp. 753-760. London: International Medical Press
Telenti, Amalio; Egger, Matthias (2007). Identifying safety concerns from genetic data: lessons from the development of CCR5 inhibitors. Antiviral therapy, 12(2), pp. 147-8. London: International Medical Press
Keiser, Olivia; Fellay, Jacques; Opravil, Milos; Hirsch, Hans H; Hirschel, Bernard; Bernasconi, Enos; Vernazza, Pietro L; Rickenbach, Martin; Telenti, Amalio; Furrer, Hansjakob (2007). Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antiviral therapy, 12(8), pp. 1157-64. London: International Medical Press
Fux, CA; Simcock, M; Wolbers, M; Bucher, HC; Hirschel, B; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Elzi, L; Furrer, H; Swiss, HIV Cohort Study (2007). Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy, 12(8), pp. 1165-73. London: International Medical Press
Simcock, M; Blasko, M; Karrer, U; Bertisch, B; Pless, M; Blumer, L; Vora, S; Robinson, JO; Bernasconi, E; Terziroli, B; Moirandat-Rytz, S; Furrer, H; Hirschel, B; Vernazza, P; Sendi, P; Rickenbach, M; Bucher, HC; Battegay, M; Koller, MT and Swiss, HIV Cohort Study (2007). Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Antiviral therapy, 12(6), pp. 931-9. London: International Medical Press
Wolbers, M; Battegay, M; Hirschel, B; Furrer, H; Cavassini, M; Hasse, B; Vernazza, PL; Bernasconi, E; Kaufmann, G; Bucher, HC; Swiss, HIV Cohort Study (2007). CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy, 12(6), pp. 889-97. London: International Medical Press
Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob (2007). Late presentation of HIV-infected individuals. Antiviral therapy, 12(6), pp. 841-51. London: International Medical Press
Rotger, Margalida; Colombo, Sara; Furrer, Hansjakob; Décosterd, Laurent; Buclin, Thierry; Telenti, Amalio (2007). Does tenofovir influence efavirenz pharmacokinetics? Antiviral therapy, 12(1), pp. 115-8. London: International Medical Press
Wunder, DM; Bersinger, NA; Fux, CA; Mueller, NJ; Hirschel, B; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Mueller, B; Furrer, H; HIV Cohort Study, Swiss (2007). Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy, 12(2), pp. 261-5. London: International Medical Press
Young, J; Weber, R; Rickenbach, M; Furrer, H; Bernasconi, E; Hirschel, B; Tarr, PE; Vernazza, P; Battegay, M; Bucher, HC (2005). Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antiviral therapy, 10(5), pp. 585-91. London: International Medical Press
Young, J; Rickenbach, M; Weber, R; Furrer, H; Bernasconi, E; Hirschel, B; Tarr, PE; Vernazza, P; Battegay, M; Bucher, HC (2005). Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Antiviral therapy, 10(1), pp. 73-81. London: International Medical Press
Harris, Ross J; Sterne, Jonathan A C; Abgrall, Sophie; Dabis, François; Reiss, Peter; Saag, Michael; Phillips, Andrew N; Chêne, Geneviève; Gill, John M; Justice, Amy C; Rockstroh, Jürgen; Sabin, Caroline A; Mocroft, Amanda; Bucher, Heiner C; Hogg, Robert S; Monforte, Antonella D'Arminio; May, Margaret; Egger, Matthias (2008). Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antiviral therapy, 13(8), pp. 959-67. London: International Medical Press
Keiser, Olivia; Egger, Matthias (2008). Reporting of observational studies in Antiviral Therapy: a case for STROBE? Antiviral therapy, 13(6), pp. 743-5. London: International Medical Press
Fux, Christoph A; Rauch, Andri; Simcock, Mathew; Bucher, Heiner C; Hirschel, Bernard; Opravil, Milos; Vernazza, Pietro; Cavassini, Matthias; Bernasconi, Enos; Elzi, Luigia; Furrer, Hansjakob (2008). Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1077-82. London: International Medical Press
Rauch, Andri; Nolan, David; Thurnheer, Christine; Fux, Christoph A; Cavassini, Matthias; Chave, Jean-Philippe; Opravil, Milos; Phillips, Elizabeth; Mallal, Simon; Furrer, Hansjakob (2008). Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1019-28. London: International Medical Press
Rauch, Andri; Gaudieri, Silvana; Evison, John; Nolan, David; Cavassini, Matthias; Weber, Rainer; James, Ian; Furrer, Hansjakob (2008). Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral therapy, 13(3), pp. 455-60. London: International Medical Press
Glass, Tracy R; De Geest, Sabina; Hirschel, Bernard; Battegay, Manuel; Furrer, Hansjakob; Covassini, Matthias; Vernazza, Pietro L; Bernasconi, Enos; Rickenboch, Martin; Weber, Rainer; Bucher, Heiner C (2008). Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, 13(1), pp. 77-85. London: International Medical Press
Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462
Young, Jim; Bucher, Heiner C; Guenthard, Huldrych F; Rickenbach, Martin; Fux, Christoph A; Hirschel, Bernard; Cavassini, Matthias; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel (2009). Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy, 14(6), pp. 771-9. London: International Medical Press 10.3851/IMP1291
Tschochner, Monika; Chopra, Abha; Maiden, Tanya M; Ahmad, Imran F; James, Ian; Furrer, Hansjakob; Günthard, Huldrych F; Mallal, Simon; Rauch, Andri; John, Mina (2009). Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance. Antiviral therapy, 14(7), pp. 953-64. London: International Medical Press 10.3851/IMP1419
Conen, Anna; Fehr, Jan; Glass, Tracy R; Furrer, Hansjakob; Weber, Rainer; Vernazza, Pietro; Hirschel, Bernard; Cavassini, Matthias; Bernasconi, Enos; Bucher, Heiner C; Battegay, Manuel (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy, 14(3), pp. 349-57. London: International Medical Press
Wandeler, Gilles; Gerber, Florian; Rohr, Julia; Chi, Benjamin H; Orrell, Catherine; Chimbetete, Cleophas; Prozesky, Hans; Boulle, Andrew; Hoffmann, Christopher J; Gsponer, Thomas; Fox, Matthew P; Zwahlen, Marcel; Egger, Matthias; Africa, Iedea Southern (2014). Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa. Antiviral therapy, 19(5), pp. 521-525. International Medical Press 10.3851/IMP2710
Rohrbach, Janine; Stickel, Felix; Schmid, Patrick; Thormann, Wolfgang; Kovari, Helen; Scherrer, Alexandra; Günthard, Huldrych F.; Vuichard, Danielle; Cavassini, Matthias; Ambrosioni, Juan; Bernasconi, Enos; Furrer, Hansjakob; Rauch, Andri; Swiss HIV Cohort Study, The (2013). Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV/HCV-coinfected individuals. Antiviral therapy, 19(2), pp. 149-159. International Medical Press 10.3851/IMP2686
Boillat-Blanco, Noémie; Darling, Katharine Ea; Schoni-Affolter, Franziska; Vuichard, Danielle; Rougemont, Mathieu; Fulchini, Rosamaria; Bernasconi, Enos; Aouri, Manel; Clerc, Olivier; Furrer, Hansjakob; Günthard, Huldrych F; Cavassini, Matthias (2014). Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antiviral therapy, 20(2), pp. 165-175. International Medical Press 10.3851/IMP2815
Guidi, Monia; Foletti, Giuseppe; McLaren, Paul; Cavassini, Matthias; Rauch, Andri; Tarr, Philip E; Lamy, Olivier; Panchaud, Alice; Telenti, Amalio; Csajka, Chantal; Rotger, Margalida (2014). Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry. Antiviral therapy, 20(3), pp. 261-269. International Medical Press 10.3851/IMP2823
Neukam, Karin; Munteanu, Daniela; Haubitz, Sebastian; Mira, José A; Ingiliz, Patrick; Rivero-Juárez, Antonio; Lutz, Thomas; de Los Santos-Gil, Ignacio; Scholten, Stefan; Márquez, Manuel; Rauch, Andri; Rockstroh, Jürgen K.; Pineda, Juan A. (2014). Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection. Antiviral therapy, 20(4), pp. 407-413. International Medical Press 10.3851/IMP2921
Young, Jim; Scherrer, Alexandra U; Calmy, Alexandra; Tarr, Philip E; Bernasconi, Enos; Cavassini, Matthias; Hachfeld, Anna; Vernazza, Pietro; Günthard, Huldrych F; Bucher, Heiner C (2019). The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antiviral therapy, 24(5), pp. 343-353. International Medical Press 10.3851/IMP3310
Haupts, Stefan; Ledergerber, Bruno; Böni, Jörg; Schüpbach, Jörg; Kronenberg, Andreas; Opravil, Milos; Flepp, Markus; Speck, Roberto F; Grube, Christina; Rentsch, Katharina; Weber, Rainer; Günthard, Huldrych F (2003). Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Antiviral therapy, 8(5), pp. 443-454. International Medical Press
Kusejko, Katharina; Marzel, Alex; Nguyen, Huyen; Chaudron, Sandra E; Bachmann, Nadine; Weber, Rainer; Bruggmann, Philip; Roth, Jan A; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Bregenzer, Andrea; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Walti, Laura N.; Günthard, Huldrych F; Kouyos, Roger D (2020). Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018. Antiviral therapy, 25(1), pp. 43-54. International Medical Press 10.3851/IMP3347
